Search Page

1

Cite

Share

Characteristics of new HIV diagnoses over 1995-2019: A clinic-based study in Montréal, Canada.

Giguère K, Vaziri M, Olivier C, Charest L, Szabo J, Thomas R, Maheu-Giroux M. Giguère K, et al. Among authors: charest l. PLoS One. 2021 Oct 7;16(10):e0258383. doi: 10.1371/journal.pone.0258383. eCollection 2021. PLoS One. 2021. PMID: 34618875 Free PMC article.

Cite

Share

2

Cite

Share

Asymptomatic urethral lymphogranuloma venereum: a case report.

Charest L, Fafard J, Greenwald ZR. Charest L, et al. Int J STD AIDS. 2018 Jul;29(8):828-830. doi: 10.1177/0956462417751813. Epub 2018 Jan 19. Int J STD AIDS. 2018. PMID: 29350113

Cite

Share

3

Cite

Share

The increased susceptibility of women to multiple sclerosis.

Duquette P, Pleines J, Girard M, Charest L, Senecal-Quevillon M, Masse C. Duquette P, et al. Among authors: charest l. Can J Neurol Sci. 1992 Nov;19(4):466-71. Can J Neurol Sci. 1992. PMID: 1423044 Review.

Cite

Share

4

Cite

Share

Acceptability of anal cancer screening tests for women living with HIV in the EVVA study.

Kaufman E, de Castro C, Williamson T, Lessard B, Munoz M, Mayrand MH, Burchell AN, Klein MB, Charest L, Auger M, Marcus V, Coutlée F, de Pokomandy A; EVVA Study Group. Kaufman E, et al. Among authors: charest l. Curr Oncol. 2020 Feb;27(1):19-26. doi: 10.3747/co.27.5401. Epub 2020 Feb 1. Curr Oncol. 2020. PMID: 32218656 Free PMC article.

Cite

Share

5

Cite

Share

Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV.

Nguyen VK, Greenwald ZR, Trottier H, Cadieux M, Goyette A, Beauchemin M, Charest L, Longpré D, Lavoie S, Tossa HG, Thomas R. Nguyen VK, et al. Among authors: charest l. AIDS. 2018 Feb 20;32(4):523-530. doi: 10.1097/QAD.0000000000001718. AIDS. 2018. PMID: 29239887 Free PMC article.

Cite

Share

6

Cite

Share

Pre-exposure Prophylaxis Uptake Among Men Who Have Sex With Men Who Used nPEP: A Longitudinal Analysis of Attendees at a Large Sexual Health Clinic in Montréal (Canada).

Xia Y, Greenwald ZR, Milwid RM, Trottier C, Boissonnault M, Gaul N, Charest L, Landry G, N Zahedi N, Szabo J, Thomas R, Maheu-Giroux M. Xia Y, et al. Among authors: charest l. J Acquir Immune Defic Syndr. 2020 Dec 1;85(4):408-415. doi: 10.1097/QAI.0000000000002472. J Acquir Immune Defic Syndr. 2020. PMID: 33136737

Cite

Share

7

Cite

Share

Tolerability is more important than simplicity for treatment durability.

Trottier B, Machouf N, Huchet E, Lavoie S, Vezina S, Boissonnault M, Charest L, Munoz M, Legault D, Longpré D, Thomas R. Trottier B, et al. Among authors: charest l. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19765. doi: 10.7448/IAS.17.4.19765. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397509 Free PMC article.

Cite

Share

8

Cite

Share

Sequence-specific backbone resonance assignments and microsecond timescale molecular dynamics simulation of human eosinophil-derived neurotoxin.

Gagné D, Narayanan C, Bafna K, Charest LA, Agarwal PK, Doucet N. Gagné D, et al. Among authors: charest la. Biomol NMR Assign. 2017 Oct;11(2):143-149. doi: 10.1007/s12104-017-9736-9. Epub 2017 Mar 7. Biomol NMR Assign. 2017. PMID: 28271277 Free PMC article.

Cite

Share

9

Cite

Share

Correction to: Sequence-specific backbone resonance assignments and microsecond timescale molecular dynamics simulation of human eosinophil-derived neurotoxin.

Gagné D, Narayanan C, Bafna K, Charest LA, Agarwal PK, Doucet N. Gagné D, et al. Among authors: charest la. Biomol NMR Assign. 2018 Oct;12(2):365-367. doi: 10.1007/s12104-018-9833-4. Biomol NMR Assign. 2018. PMID: 30083869

Cite

Share

10

Cite

Share

Identifying risk factors for prevalent anal human papillomavirus type 16 infection in women living with HIV.

Kaufman E, Williamson T, Mayrand MH, Burchell AN, Klein M, Charest L, Rodrigues-Coutlée S, Coutlée F, de Pokomandy A; EVVA study group. Kaufman E, et al. Among authors: charest l. PLoS One. 2022 May 19;17(5):e0268521. doi: 10.1371/journal.pone.0268521. eCollection 2022. PLoS One. 2022. PMID: 35587503 Free PMC article.

Cite

Share